CFDE Data Portal | Search NLGN4Y

	Label	Description
	NLGN4Y Gene (Entity type)	ENSG00000165246 - neuroligin 4 Y-linked
	NLGN4Y associations Collection (Entity type)	Associations for NLGN4Y_associations
	NLGN4Y associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NLGN4Y-AS1 associations Collection (Entity type)	Associations for NLGN4Y-AS1_associations
	NLGN4Y-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NLGN4Y-AS1 Gene (Entity type)	ENSG00000228787 - NLGN4Y antisense RNA 1
	GSE135350 2 V 4 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE96649 1 V 0 DEXAMETHASONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

NLGN4Y

ENSG00000165246 - neuroligin 4 Y-linked

NLGN4Y associations

Associations for NLGN4Y_associations

NLGN4Y associations.tsv

A file from IDG as part of the Harmonizome project

NLGN4Y-AS1 associations

Associations for NLGN4Y-AS1_associations

NLGN4Y-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

NLGN4Y-AS1

ENSG00000228787 - NLGN4Y antisense RNA 1

GSE135350 2 V 4 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE226249 pirfenidone HL 2 v 1 human up

A Gene Set from LINCS

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE96649 1 V 0 DEXAMETHASONE HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.